FIELD: medicine; cardiology.
SUBSTANCE: prevention of heart rhythm disorder is ensured with intramuscular introduction of 5-oxynicotinic acid derivative "ЛБК"-149 dosed 25 mg/kg once a day within 10 days, accompanied with simulated lipidosis and carbohydrate metabolic imbalance and followed with simulated early occlusive and reperfusion arrhythmias.
EFFECT: effective prevention of arrhythmias combined with minimum cardiotoxic effects.
2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ETHYMIZOLE APPLICATION AS ANTI-ARRHYTHMIA PREPARATION FOR PREVENTING VENTRICULAR EXTRASYSTOLE IN MYOCARDIAL ISCHEMIA PATIENTS | 1997 |
|
RU2148999C1 |
| METHOD OF PREVENTING LIPID EXCHANGE DISORDERS | 2009 |
|
RU2423123C1 |
| PHARMACEUTICAL COMPOSITION WITH ANTIARRHYTHMIC ACTIVITY OF VARIOUS ETIOLOGIES | 2021 |
|
RU2783944C1 |
| AGENT FOR METABOLIC SYNDROME CORRECTION | 2011 |
|
RU2458935C1 |
| COMPOSITION OF AMINO ACIDS WITH TRACE ELEMENTS ELICITING ANTIARRHYTHMIC ACTIVITY | 1999 |
|
RU2173553C2 |
| ANTI-ARRHYTHMIC AGENT | 2005 |
|
RU2320342C2 |
| 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE AND NICOTINIC ACID SALT, HAVING HYPOGLYCEMIC, HYPOLIPIDEMIC AND NEUROPROTECTIVE ACTIVITY AND SYNTHESIS METHOD THEREOF | 2010 |
|
RU2454406C2 |
| AGENT ELICITING ANTI-ISCHEMIC, HYPOTENSIVE, ANTI- -ARRHYTHMIC AND NOOTROPIC ACTIVITY | 2002 |
|
RU2216322C1 |
| APPLICATION OF GLUTARIC ACID DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AS ANTIARRHYTHMIC DRUG | 2008 |
|
RU2373934C1 |
| QUATERNARY AMMONIUM DERIVATIVE OF NOVOCAIN, WHICH POSSESSES ANTI-ARRHYTHMIC ACTIVITY, AND METHOD OF ITS OBTAINING | 2009 |
|
RU2414893C1 |
